fig1
![Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteins](https://image.oaes.cc/15194aea-824c-4128-a3b0-98f75a56d12c/3115.fig.1.jpg)
Figure 1. Main types and composition of nanocarriers used for cancer treatment and/or imaging (A); how can the nanocarrier be modified to target cancer cells (B)
Figure 1. Main types and composition of nanocarriers used for cancer treatment and/or imaging (A); how can the nanocarrier be modified to target cancer cells (B)
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/